To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The head of the machinists union ...
FRANKFURT, Sept 30 (Reuters) - ABO Energy (AB9.DE), opens new tab has mandated private bank Metzler to advise it on a deal that could see the German renewables firm's founders cede control to an ...
Climate watchers need to look beyond China to gain a full read on global emissions trends tied to energy extraction and generation. To be sure, China has played an outsized role in driving global ...
In this article, we discuss 11 Best Nuclear Energy Stocks to Invest in Right Now. Last month, President Trump signed an executive order to slash red tape and quadruple the nation’s nuclear capacity, ...
Innovation Beverage Group (IBG) shares more than doubled in early trading on Tuesday after the company announced it has entered into a non-binding letter of intent for a merger with BlockFuel Energy.
Following the Trump administration's plans to explore whether a widely available generic medication called leucovorin could cure autism, GSK (NYSE:GSK), which once manufactured and marketed the ...
SEVEN HILLS, Australia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Innovation Beverage Group Ltd, (“IBG” or the “Company”) (Nasdaq: IBG), an innovative developer, manufacturer, and marketer of a growing ...
--Gold futures are down 1.2% to $3,673 a troy ounce --LME three-month copper futures are down 0.4% to $9,935.50 a metric ton Octopus Energy to Spin Off AI Arm Kraken to Create Potential $15 Billion ...
British renewable-energy startup Octopus Energy is spinning off its artificial intelligence arm, Kraken, in what could create a stand-alone entity worth $15 billion. Kraken has operated in Octopus’s ...
Experiments at San Diego's DIII-D National Fusion Facility have demonstrated that a new plasma configuration could help increase the stability of tokamak fusion reactors and inform future designs.
Novo Nordisk NVO has secured European approval to update the label of oral GLP-1 drug for type II diabetes (T2D), Rybelsus (oral semaglutide), to reflect cardiovascular benefits demonstrated in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results